Alliance Pharma (LON:APH) has acquired the rights to Smith & Nephew‘s (NYSE:SNN) anesthetic gel Ametop for $7.5 million, according to the specialty pharmaceutical company.
The product, which Smith & Nephew has been selling in the U.K., Ireland, New Zealand and Canada for at least 10 years, is designed to numb a patient’s skin before an injection.
Get the full story at our sister site, Drug Delivery Business News.
The post Smith & Nephew deals topical anesthetic gel to Alliance Pharma appeared first on MassDevice.